CORONA Remedies secures EAEU-GMP Certification

22 Jan 2026 Evaluate

CORONA Remedies has secured Eurasian Economic Union - Good Manufacturing Practices (EAEU-GMP) Certification for its finished dosage facility situated at Bhayla, Gujarat. This certification paves the way for the company’s entry into five EAEU member nations -- Russia, Kyrgyzstan, Armenia, Belarus, and Kazakhstan -- under a B2B business model. 

It unlocks access to a pharmaceutical market estimated at $25 billion and aligns seamlessly with the company’s long-term vision of fostering sustainable international partnerships. EAEU-GMP certification further strengthens the company’s focus across its four key therapeutic pillars -- Women’s Health, Cardio-Diabetes, Pain Management, and Urology.  

CORONA Remedies is primarily engaged in the business of manufacturing, trading and marketing of pharmaceutical products.

CORONA Remedies Share Price

1386.00 -1.30 (-0.09%)
22-Jan-2026 16:00 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1634.40
Dr. Reddys Lab 1217.15
Cipla 1374.60
Zydus Lifesciences 883.85
Lupin 2165.30
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×